Cryo-Cell International Inc (CCEL)
NYSE MKT:CCEL

Cryo-Cell International (CCEL) Stock Price & Analysis

20 Followers

CCEL Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.69 - $8.12
Previous Close$3.05
Volume4.45K
Average Volume (3M)9.66K
Market Cap
$25.75M
Enterprise Value$35.64M
Total Cash (Recent Filing)$1.72M
Total Debt (Recent Filing)$11.61M
Price to Earnings (P/E)9.4
Beta0.28
Apr 17, 2023
EPS EstimateN/A
0.9 (29.57%)
Share Statistics
EPS (TTM)0.32
Shares Outstanding8,453,717
10 Day Avg. Volume18,483
30 Day Avg. Volume9,658
Standard Deviation0.10
R-Squared0.00647
Alpha-0.00218
Financial Highlights & Ratios
Price to Book (P/B)-1.39
Price to Sales (P/S)1.09
Price to Cash Flow (P/CF)3.00
P/FCF Ratio-2.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.17
Enterprise Value/Gross Profit1.65
Enterprise Value/Ebitda5.36
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering1


Financials

Annual

CCEL FAQ

What was Cryo-Cell International Inc’s price range in the past 12 months?
Cryo-Cell International Inc lowest stock price was $2.69 and its highest was $8.12 in the past 12 months.
    What is Cryo-Cell International Inc’s market cap?
    Currently, no data Available
    When is Cryo-Cell International Inc’s upcoming earnings report date?
    Cryo-Cell International Inc’s upcoming earnings report date is Apr 17, 2023 which is in 17 days.
      How were Cryo-Cell International Inc’s earnings last quarter?
      Cryo-Cell International Inc released its earnings results on Feb 28, 2023. The company reported $0.13 earnings per share for the quarter, beating the consensus estimate of -$0.03 by $0.16.
        Is Cryo-Cell International Inc overvalued?
        According to Wall Street analysts Cryo-Cell International Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Cryo-Cell International Inc pay dividends?
          Cryo-Cell International Inc pays a Notavailable dividend of $0.9 which represents an annual dividend yield of 29.57%. See more information on Cryo-Cell International Inc dividends here
            What is Cryo-Cell International Inc’s EPS estimate?
            Cryo-Cell International Inc’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Cryo-Cell International Inc have?
            Cryo-Cell International Inc has 8,443,316 shares outstanding.
              What happened to Cryo-Cell International Inc’s price movement after its last earnings report?
              Cryo-Cell International Inc reported an EPS of $0.13 in its last earnings report, beating expectations of -$0.03. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Cryo-Cell International Inc?
                Currently, no hedge funds are holding shares in CCEL

                ---

                Cryo-Cell International Stock Smart Score

                N/A
                Not Ranked
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -55.39%
                12-Months-Change

                Fundamentals

                Return on Equity
                208.38%
                Trailing 12-Months
                Asset Growth
                6.97%
                Trailing 12-Months
                This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                Learn more about TipRanks Smart Score

                Company Description

                Cryo-Cell International Inc

                Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation service and to advance regenerative medicine. It operates through the following segments: Cellular Processing and Cryogenic Storage; and Prepacyte CB. The Cellular Processing and Cryogenic Storage segment focuses on the collection and preservation of umbilical cord blood and tissue stem cells for family use. The Prepacyte CB segment refers to the processing technology used to process umbilical cord blood stem cells. The company was founded on September 11, 1989 and is headquartered in Oldsmar, FL.

                ---

                Top 5 ETFs holding CCEL

                Currently, no data available
                Please return soon. This page is being updated.
                Up to five ETFs with an Outperform Smart Score that hold CCEL. The ETFs are listed according to market value of CCEL within the ETF

                ---

                Forecast EPS vs Actual EPS


                Similar Stocks
                Company
                Price & Change
                Follow
                Enzo Biochem
                ATI Physical Therapy
                Bitech Technologies Corporation
                Medical Marijuana

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis